NK

Naresh Kumar

Active Director Director DIN 09317476
DIN 09317476 First appointment Sep 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Naresh Kumar

Data last updated:

Naresh Kumar is a Director at Indmark Biotech Private Limited (since 2021). The company operates in Pharma. Indmark Biotech Private Limited reported revenue of ₹1.03 Cr (FY 2025).

DIN 09317476
Primary Designation Director
Industry Pharma
First Appointment 13 Sep 2021
Oldest Company Age 5 yrs
Largest company Indmark Biotech Private Limited · ₹1.03 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indmark Biotech Private Limited U24290HR2021PTC097637
Director13 Sep 20212021₹1.03 Cr (FY 2025)Active

Board colleagues of Naresh Kumar

NameDINCompanyDesignation
Mandeep Singh09317477Indmark Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Indmark Biotech Private Limited
Premium access

Shareholding and investment profile for Naresh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naresh Kumar

Naresh Kumar currently holds 1 directorship: Indmark Biotech Private Limited (Director, since 13 Sep 2021, revenue ₹1.03 Cr (FY 2025)).

Naresh Kumar was first appointed on 13 Sep 2021 as Director at Indmark Biotech Private Limited.

The current boards of Naresh Kumar's companies include Mandeep Singh (Indmark Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available